Analysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl)phthalate released by multilayer infusion tubing

Journal of Pharmaceutical and Biomedical Analysis

Volumn 35, Issue 1, 2004, Pages 57-64

  Bourdeaux, Daniel ^a   Sautou Miranda, Valérie ^a,b   Bagel Boithias, Sandrine ^a   Boyer, Anne ^a,b   Chopineau, Jean ^a,b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

DEHP; Etoposide; FT IR; HPLC; Polysorbate; PVC

Indexed keywords

CELLTOP; ETOPOSIDE; EXCIPIENT; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLASTICIZER; POLYSORBATE; POLYVINYLCHLORIDE;

ANALYTIC METHOD; ARTICLE; CHEMICAL ANALYSIS; CHROMATOGRAPHY; DRUG SOLUTION; HEALTH HAZARD; INFRARED SPECTROMETRY; LIQUID CHROMATOGRAPHY; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; TUBE;

CHROMATOGRAPHY, LIQUID; DIETHYLHEXYL PHTHALATE; DRUG CONTAMINATION; EQUIPMENT SAFETY; ETOPOSIDE; INFUSION PUMPS; PLASTICIZERS; PLASTICS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 1642308031     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2003.12.018     Document Type: Article

References (17)

1. Pearson S.D., Trissel L.A. Am. J. Hosp. Pharm. 50:1993;1405-1409.
2. US Food and Drug Administration, Center for Devices and Radiological Health, Safety assessment of di(2-ethylhexyl)phtalate (DEHP) released from PVC medical devices, Rockville, 2001.
3. Tickner J.A., Schettler T., Guidotti T., McCally M., Rossi M. Am. J. Ind. Med. 39:2001;100-111.
4. Health Canada, Medical devices Bureau, DEHP in medical devices: an exposure and toxicity assessment, 2002.
5. National Toxicology Program, Center for the evaluation of risks to human reproduction: phtalate expert panel report on the reproductive developmental toxicity of di(2-ethylhexyl)phtalate. Reprod. Toxicol. 16 (2002) 529-653.
6. Huber W.W., Grasl-Karaup B., Schulte-Hermann R. Crit. Rev. Toxicol. 26:1996;365-481.
7. Park J.D., Habeebou S.S.M., Curtis D., Klaassen D. Toxicology. 171:2002;105-115.
8. Doull J., Cattley R., Elcombe C., Lake B.G., Swenberg J., Wilkinson C., Williams G., Van Gemert M. Regul. Toxicol. Pharmacol. 29:1999;327-357.
9. M. Rossi, Neonatal exposure to DEHP and opportunities for prevention, Health Care without Harm, Falls Church, 2000.
10. Shea K.M. Pediatrics. 111:2003;1467-1474.
11. Gras C., Sautou-Miranda V., Bagel-Boithias S., Brigas F. J. Chopineau. EJHP. 8:2002;33-40.
12. Loff S., Kabs F., Witt K., Sartoris J., Mandl B., Niessen K.H., Waag K.L. J. Ped. Surg. 35:2000;1775-1781.
13. Loff S., Kabs F., Subotic U., Schaible T., Reinecke F., Langbein M. J. Parenter. Enteral. Nutr. 26:2002;305-309.
14. Demoré B., Vigneron J., Perrin A., Hoffman M.A., Hoffman M. J. Clin. Pharm. Ther. 27:2002;139-142.
15. Jobet-hermelin I., Mallevais M.L., Jacquot C., Prugnaud J.L. J. Pharm. Clin. 15:1996;132-136.
16. Kambia K., Dine T., Azar R., Gressier B., Luyckx M., Brunet C. Int. J. Pharm. 229:2001;139-146.
17. Lakshmi S., Jayakrishnan A. Artif. Organs. 22:1998;222-229.